相关实验视频

Updated: Jan 6, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

血友病基因治疗的最新进展

Xiaojuan Pang¹, Jinxian Fu², Zhongqi Zhou³

¹Applied Research Center for Genetic Resources of Bioactive Substances, Guangdong Xin'an Polytechnic, Shenzhen, Guangdong, China.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

|September 10, 2025

概括

基因疗法通过使用腺相关病毒 (AAV) 载体来提供凝固因子,为血友病提供了有前途的治疗方法. 虽然有效,但成本和免疫性等挑战需要进一步研究以获得更广泛的患者.

科学领域:

* 遗传学和分子生物学
* 血液学血液学
* 基因治疗基因治疗

背景情况:

*血友病是一种X系单基因疾病,由F8或F9基因突变引起,导致凝固因子缺乏.
*临床表现包括自发出血,严重病例可能导致中风和关节病,影响生活质量.
* 血友病的单一性质和可预测的结果使得血友病成为基因治疗的主要目标.

研究的目的:

* 提供对近期血友病基因治疗进展的全面审查.
*专注于临床翻译和该领域的技术创新.
* 突出克服现有障碍和提高治疗可获得性的战略.

主要方法:

*对当前食品和药物管理局 (FDA) 批准的使用重组腺相关病毒 (AAV) 载体的基因疗法的审查.
*对功能转基因盒向肝细胞传递AAV载体的分析.
* 检查持续的凝血因子活性和患者的结果.

主要成果:

*FDA批准的基于AAV的基因疗法在一次剂量后提供持续的第八因子 (FVIII) 和第九因子 (FIX) 活性.
* 这些疗法显示出强大的静血控制和显著改善患者的生活质量.
* 挑战仍然存在,包括免疫性,血栓形成风险,潜在的基因整合和高成本.

结论:

* 血友病基因疗法显示出持续治疗和改善生活质量的显著前景.
*未来的研究必须解决患者资格,成本和安全问题等局限性问题.
* 整合精确的基因编辑技术对于提高血友病治疗潜力至关重要.

关键词:

腺相关病毒的病毒.凝血因子是什么?凝血因子是什么?基因传递基因传递基因传递基因治疗的基因疗法血友病A型血友病A型血友病A型血友病 B 型血友病 B 型

更多相关视频

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection

Published on: February 2, 2018

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

What is Genetic Engineering?

What is Genetic Engineering?

Recombinant DNA

Recombinant DNA